SpyGlass in Post Liver Transplant Biliary Complications.
Prospective Evaluation of SpyGlass Direct Visualization System in Post Liver Transplant Biliary Stricture.
Sponsor: Hospital Israelita Albert Einstein
This NA trial investigates Biliary Anastomosis Complication and Liver Transplant Disorder and is currently completed. Hospital Israelita Albert Einstein leads this study, which shows 11 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
May 2019 — Jan 2021 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Dec 2018 — May 2019 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jul 2018 — Dec 2018 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital Israelita Albert Einstein
For direct contact, visit the study record on ClinicalTrials.gov .